ANTIBIOTIC RESISTANCE: CAUSES, GLOBAL HEALTH IMPACTS, AND FUTURE STRATEGIES FOR PREVENTION AND TREATMENT
DOI:
https://doi.org/10.37547/Keywords:
antibiotics, antibiotic resistance, bacteria, infection, antibacterial therapy, rational antibiotic use, prevention, global health, treatment strategies.Abstract
Antibiotic resistance is one of the most serious challenges facing modern healthcare. Incorrect and uncontrolled use of antibiotics, failure to complete the full course of treatment, self-medication, and excessive use of antibiotics in medicine and animal farming contribute to the development of resistant bacteria. As a result, common infections become more difficult to treat, hospital stays become longer, treatment costs increase, and the risk of severe complications rises. This article discusses the main causes of antibiotic resistance and its impact on human health and the global healthcare system. It also describes important future approaches, including the rational use of antibiotics, prevention of infections, development of new antibacterial drugs, vaccination, and alternative treatment methods. Effective control of antibiotic resistance requires close cooperation between healthcare professionals, patients, and health organizations.
Downloads
References
1. GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199–1226. doi:10.1016/S0140-6736(24)01867-1.
2. World Health Organization. Global Antibiotic Resistance Surveillance Report 2025. Geneva: WHO; 2025.
3. World Health Organization. WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance. Geneva: WHO; 2024.
4. World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: Antibiotic Use Data for 2022. Geneva: WHO; 2025.
5. World Health Organization, Food and Agriculture Organization of the United Nations, United Nations Environment Programme, World Organisation for Animal Health. Implementing the Global Action Plan on Antimicrobial Resistance: First Quadripartite Biennial Report. Geneva: WHO; 2024.
6. Qin X, Ding L, Hao M, Li P, Hu F, Wang M. Antimicrobial resistance of clinical bacterial isolates in China: current status and trends. JAC Antimicrob Resist. 2024;6(2). doi:10.1093/jacamr/dlae052.
7. Malik S, Shirvankar CM, Jacob RK, et al. A systematic review and meta-analysis to develop a landscape map of antibiotic resistance for six WHO priority pathogens in east and north-east India from 2011 to 2022. Indian J Med Microbiol. 2024;52:100732. doi:10.1016/j.ijmmb.2024.100732.
8. Mirha HT, Ali SH, Aamar H, et al. The impact of antibiotic resistance on the rampant spread of infectious diseases in Pakistan: insights from a narrative review. Health Sci Rep. 2024;7(4). doi:10.1002/hsr2.2050.
9. Kiran MA, Alghamdi S, Ashgar S, Alhindi Z, Al-Abdullah N, Dablool AS. Systematic review and meta-analysis on antimicrobial resistance and drug resistance in Saudi Arabia. J Glob Antimicrob Resist. 2024;39:128–136. doi:10.1016/j.jgar.2024.07.013.
10. Antimicrobial Resistance Collaborators. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. Lancet Glob Health. 2024;12(2)–e216. doi:10.1016/S2214-109X(23)00539-9.
11. Essack SY, Lenglet A. Bacterial antimicrobial resistance burden in Africa: accuracy, action, and alternatives. Lancet Glob Health. 2024;12(2)–e172. doi:10.1016/S2214-109X(23)00587-9.
12. Halawa EM, Fadel M, Al-Rabia MW, et al. Antibiotic action and resistance: updated review of mechanisms, spread, influencing factors, and alternative approaches for combating resistance. Front Pharmacol. 2024;14:1305294. doi:10.3389/fphar.2023.1305294.
13. Onah SI, Umar HJ. Appraising Nigeria's approach to combating antimicrobial resistance. Int J Health Plann Manage. 2024;39(2):556–562. doi:10.1002/hpm.3717.
14. European Centre for Disease Prevention and Control. Antimicrobial Resistance in the EU/EEA (EARS-Net): Annual Epidemiological Report for 2023. Stockholm: ECDC; 2024.
15. UK Health Security Agency. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR), 2024 to 2025 Report. London: UKHSA; 2026.
16. Australian Centre for Disease Control. Sixth Australian Report on Antimicrobial Use and Resistance in Human Health. Canberra: Australian Government; 2026.
17. Carneiro M, Pillonetto M. Fighting antimicrobial resistance in Brazil: strengthening diagnostic stewardship, antimicrobial stewardship, and policies for a healthier future. Front Public Health. 2026;13:1726000. doi:10.3389/fpubh.2025.1726000.
18. World Health Organization. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024.
19. Zhazykhbayeva D., Kosherova Z., Turdalina B., Almazan J., Aljofan M., Semenova Y. From surveillance to stewardship: addressing antimicrobial resistance in Central Asia’s healthcare. Clinical Microbiology Reviews. 2026;39(2). doi:10.1128/cmr.00198-25.
20. Zhazykhbayeva D, Bayesheva D, Kosherova Z, Semenova Y. Antimicrobial resistance surveillance in post-Soviet countries: a systematic review. Antibiotics (Basel). 2024;13(12):1129. doi:10.3390/antibiotics13121129.
21. World Health Organization Regional Office for Europe. Results of Antimicrobial Resistance Surveillance in Uzbekistan, 2019–2022. Copenhagen: WHO Regional Office for Europe; 2025. WHO/EURO:2025-12193-51965-79699.
22. Ryu H.Y., Abdul Azim A., Bhatt P.J., Uprety P., Mohayya S., Dixit D., Kirn T.J., Narayanan N. Rapid diagnostics to enhance therapy selection for the treatment of bacterial infections. Current Pharmacology Reports. 2023;9(4):198–216. doi:10.1007/s40495-023-00323-1.
23. Woolhouse MEJ. One Health approaches to tackling antimicrobial resistance. Sci One Health. 2024;3:100082. doi:10.1016/j.soh.2024.100082.
24. Ajayi AO, Odeyemi AT, Akinjogunla OJ, Adeyeye AB, Ayo-Ajayi I. Review of antibiotic-resistant bacteria and antibiotic resistance genes within the One Health framework. Infect Ecol Epidemiol. 2024;14(1):2312953. doi:10.1080/20008686.2024.2312953.
25. World Health Organization. 2023 Antibacterial agents in clinical and preclinical development: an overview and analysis. Geneva: World Health Organization; 2024. ISBN 978-92-4-009400-0.
26. World Health Organization. Analysis of antibacterial agents in clinical and preclinical development: overview and analysis 2025. Geneva: World Health Organization; 2025. ISBN 978-92-4-011309-1.
27. Olawade DB, Fapohunda O, Egbon E, Ebiesuwa OA, Usman SO, Faronbi AO, et al. Phage therapy: a targeted approach to overcoming antibiotic resistance. Microb Pathog. 2024;197:107088. doi:10.1016/j.micpath.2024.107088.
28. Anastassopoulou C, Ferous S, Petsimeri A, Gioula G, Tsakris A. Phage-based therapy in combination with antibiotics: a promising alternative against multidrug-resistant Gram-negative pathogens. Pathogens. 2024;13(10):896. doi:10.3390/pathogens13100896.
Fang Q, Yin X, He Y, Feng Y, Zhang L, Luo H, et al. Safety and efficacy of phage application in bacterial decolonisation: a systematic review. Lancet Microbe. 2024;5(5)–e499. doi:10.1016/S2666-5247(24)00002-8.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.
